iRhythm Technologies (IRTC) Stock Analysis & Winston Score

iRhythm Technologies makes a small, wearable heart monitor called the Zio patch. Patients wear it on their chest for up to two weeks, and it records their heart rhythm the entire time. Doctors use the data to detect irregular heartbeats, like atrial fibrillation, that shorter tests might miss. iRhythm sells primarily to hospitals, cardiology clinics, and primary care physicians across the United States. The company makes money by charging for each Zio patch used, combining the hardware with a cloud-based analysis service that processes the heart data and delivers a report to the physician. Most of its revenue comes from the US, though it has been expanding into the UK and other international markets. iRhythm's main competitive advantage is its large database of heart rhythm data and its established relationships with physicians. The biggest risk the company faces is reimbursement rates from Medicare and private insurers, which directly affect how much revenue it collects per patch.